NCT06619951

A Clinical Trial to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This study will adopt a Single-center, Single-arm, Open, Fixed Sequence design to Evaluate the Effects of Itraconazole or Rifampicin on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects.

Conditions

• Locally Advanced or Metastatic Solid Tumor

Interventions

Type	Name	Description
DRUG	VC004 and Itraconazole	A single dose of VC004 was administered in the period 1. and a single dose of VC004 and Itraconazole coadministration in the period 2.
DRUG	VC004 and rifampicin	A single dose of VC004 was administered in the period 1. and a single dose of VC004 and rifampicin coadministration in the period 2.

Timeline

• Start date: 2024-09-18
• Primary completion: 2024-10-31
• Completion: 2024-10-31
• First posted: 2024-10-01
• Last updated: 2024-12-10

Locations

1 site across 1 country: China